What personal, social, and access factors affect taking diabetes medicines
Official title: Multilevel Ecological Determinants of Medication Adherence Among Diabetes Patients: A Health Ecology-COM-B Framework Analysis
Run by University of Malaya · NCT07420634 · Data updated 2026-11-12
This project will see if patients' knowledge, beliefs, family support, healthcare communication, and access problems influence how adults with diabetes take their medicines.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | University of Malaya Academic / other |
| Locations | 1 site (Ambāla, Haryana) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07420634 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with diabetes who have been on long-term medication, can understand and complete questionnaires, and can give informed consent are ideal candidates.
✕Probably not a fit
People with acute medical emergencies, severe cognitive or psychiatric impairment, terminal illness, or those unable/unwilling to provide consent or complete questionnaires are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cross-sectional observational project uses an integrated Health Ecology and COM-B (Capability-Opportunity-Motivation-Behavior) framework to examine multilevel determinants of medication adherence in adults with diabetes. Participants who are prescribed long-term medicines complete structured questionnaires about cognitive factors, treatment beliefs, family and social support, patient–provider communication, and practical access issues such as cost and distance to care. The study analyzes how intrapersonal, interpersonal, healthcare interaction, and structural factors interact to shape medication-taking behavior. Findings will be used to identify the most important barriers and supports to inform patient-centered strategies for improving adherence.
Why it matters
Potential benefit: If successful, the findings could guide more targeted, patient-centered approaches that improve medication-taking and diabetes control.
How similar studies have gone: Prior research has repeatedly found multilevel barriers to adherence and COM-B has been used successfully in related adherence work, though fully integrated ecological-COM-B approaches remain relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Diagnosed with at least one chronic disease (e.g., diabetes mellitus, hypertension, cardiovascular disease, chronic respiratory disease, chronic kidney disease) for a minimum duration of six months * Prescribed long-term medication therapy * Able to understand and respond to the study questionnaire * Willing to provide written informed consent Exclusion Criteria: * Patients with acute medical conditions requiring immediate care * Individuals with severe cognitive impairment or psychiatric illness that would preclude reliable participation * Patients who are terminally ill * Patients unwilling to participate or provide consent
Where it's running
-
MM Superspeciality Hospital, Maharishi Markandeshwar (Deemed to be University)
Ambāla, Haryana, India Recruiting
Study contacts
- Principal investigator: Rajat Rana, PhD — University of Malaya
- Study coordinator: Rajat Rana, PhD
- Email: rajatrana91@gmail.com
- Phone: +91-9876543210
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Eversense Gemini system with new flash glucose feature — testing accuracy and safety
This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.
-
Fear of hypoglycemia in people with diabetes
This study looks at how fear of low blood sugar affects how people with diabetes take their medications and manage their diet.
-
iLet Bionic Pancreas started through primary care for adults on insulin
This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.
-
Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers
This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.